Your browser doesn't support javascript.
Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment.
Jiang, Zhidong; Feng, Bo; Zhang, Yumin; Nie, Tianqing; Liu, Hong; Li, Jia; Su, Haixia; Zhang, Leike; Zang, Yi; Zhou, Yu.
  • Jiang Z; School of Life Science and Technology, ShanghaiTech University, Shanghai, 201203, China.
  • Feng B; Lingang Laboratory, Shanghai, 201203, China.
  • Zhang Y; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Nie T; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Liu H; Shenyang Pharmaceutical University, Shenyang, 110016, China.
  • Li J; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.
  • Su H; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zhang L; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zang Y; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zhou Y; Shenyang Pharmaceutical University, Shenyang, 110016, China.
Signal Transduct Target Ther ; 8(1): 209, 2023 05 22.
Article in English | MEDLINE | ID: covidwho-2323873
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2023 Document Type: Article Affiliation country: S41392-023-01482-9

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2023 Document Type: Article Affiliation country: S41392-023-01482-9